Polymorphism of UGT1A1 and Frequency of Hyperbilirubinemia in Patients with Chronic Myeloid Leukemia Treated By Nilotinib

被引：3

作者：

Bykova, Anastasia ^{[1
]}

Abdullaev, Adhamjon ^{[1
]}

Gusarova, Galina ^{[1
]}

Chelysheva, Ekaterina ^{[1
]}

Treglazova, Svetlana ^{[1
]}

Smirnova, Svetlana ^{[1
]}

Turkina, Anna G. ^{[2
]}

机构：

[1] Healthcare Minist Russian Federat, Hematol Res Ctr, Fed State Budgetary Inst, Moscow, Russia

[2] Minist Publ Hlth Russia, Hematol Res Ctr, Moscow, Russia

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

10.1182/blood.V124.21.5538.5538

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[1] UGT1A1 gene polymorphism and frequency of hyperbilirubinemia in chronic myeloid leukemia patients treated by nilotinib
Bykova, A. V.
Turkina, A. G.
Gusarova, G. A.
Abdullaev, A. O.
Chelysheva, E. Y.
Treglazova, S. A.
Sudarikov, A. B.
GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2018, 63 (01): : 8 - 15
[2] Association between nilotinib-induced hyperbilirubinemia and UGT1A1 polymorphisms in a chronic myeloid leukemia patient
Alarcon-Payer, Carolina
Suarez, Maria Del Mar Sanchez
Roldan, Alicia Martin
Morales, Alberto Jimnez
ANTI-CANCER DRUGS, 2025, 36 (05) : 438 - 439
[3] Influence of UGT1A1*6,*27, and*28 Polymorphisms on Nilotinib-induced Hyperbilirubinemia in Japanese Patients with Chronic Myeloid Leukemia
Abumiya, Maiko
Takahashi, Naoto
Niioka, Takenori
Kameoka, Yoshihiro
Fujishima, Naohito
Tagawa, Hiroyuki
Sawada, Kenichi
Miura, Masatomo
DRUG METABOLISM AND PHARMACOKINETICS, 2014, 29 (06) : 449 - 454
[4] DISTINCT ASSOCIATIONS BETWEEN UGT1A1 GENE PROMOTER POLYMORPHISM AND HYPERBILIRUBINEMIA IN CML PATIENTS TREATED WITH NILOTINIB AND RADOTINIB
Kim, S.
Choi, S. Y.
Lee, S. E.
Yoo, H. L.
Oh, Y. J.
Lee, M. Y.
Jang, E. J.
Choi, M. Y.
Jang, M. M.
Kim, D. W.
HAEMATOLOGICA, 2015, 100 : 684 - 685
[5] UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia
Singer, J. B.
Shou, Y.
Giles, F.
Kantarjian, H. M.
Hsu, Y.
Robeva, A. S.
Rae, P.
Weitzman, A.
Meyer, J. M.
Dugan, M.
Ottmann, O. G.
LEUKEMIA, 2007, 21 (11) : 2311 - 2315
[6] UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia
J B Singer
Y Shou
F Giles
H M Kantarjian
Y Hsu
A S Robeva
P Rae
A Weitzman
J M Meyer
M Dugan
O G Ottmann
Leukemia, 2007, 21 : 2311 - 2315
[7] Distinct Associations Between UGT1A1 Gene Promoter Polymorphism and Hyperbilirubinemia in Korean CML Patients Treated with Nilotinib and Radotinib
Kim, Soo-Hyun
Choi, Soo Young
Lee, Sung-Eun
Oh, Yun Jeong
Yoo, Hae Lyun
Jang, Eun-Jung
Choi, Mi-yeon
Jang, Moon-mi
Kim, Hyeoung Joon
Kwak, Jae-Yong
Kim, Hawk
Do, Young-Rok
Kim, Dong-Wook
BLOOD, 2014, 124 (21)
[8] Hyperbilirubinemia in Lapatinib Treated Patients Is Associated with Gilbert's Syndrome UGT1A1 Polymorphism
Spraggs, C.
Budde, L. R.
Briley, L. P.
Bing, N.
Newstat, B.
Rappold, E.
Mooser, V
Cardon, L. R.
Stein, S.
CANCER RESEARCH, 2009, 69 (24) : 574S - 574S
[9] UGT1A1*28 and *6 polymorphisms and nilotinib-induced unconjugated hyperbilirubinemia in a Japanese patient with chronic myelogenous leukemia
Takada, Kohichi
Sato, Tsutomu
Iyama, Satoshi
Ono, Kaoru
Kamihara, Yusuke
Murase, Kazuyuki
Kawano, Yutaka
Hayashi, Tsuyoshi
Miyanishi, Koji
Sato, Yasushi
Kobune, Masayoshi
Takimoto, Rishu
Kato, Junji
INTERNATIONAL CANCER CONFERENCE JOURNAL, 2012, 1 (04): : 220 - 223
[10] UGT1A1*28 and *6 polymorphisms and nilotinib-induced unconjugated hyperbilirubinemia in a Japanese patient with chronic myelogenous leukemia
Kohichi Takada
Tsutomu Sato
Satoshi Iyama
Kaoru Ono
Yusuke Kamihara
Kazuyuki Murase
Yutaka Kawano
Tsuyoshi Hayashi
Koji Miyanishi
Yasushi Sato
Masayoshi Kobune
Rishu Takimoto
Junji Kato
International Cancer Conference Journal, 2012, 1 (4) : 220 - 223

← 1 2 3 4 5 →